REQUEST A DEMO
Total
USD $0.00
Search more companies

Interlife Pharma Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Interlife Pharma Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Interlife Pharma Company Limited is an enterprise based in Thailand. Its main office is in Chon Buri. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on May 30, 2026. The total number of employees is currently 109 (estimated). In its most recent financial highlights, the company reported a net sales revenue increase of 21.97% in 2024. There was a total growth of 12.89% in Interlife Pharma Company Limited’s total assets over the same period.

Headquarters
137 Moo 6
Chon Buri; Eastern Thailand; Postal Code: 20170

Contact Details: Purchase the Interlife Pharma Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Interlife Pharma Company Limited report to view the information.
Financial Auditors:
Purchase the Interlife Pharma Company Limited report to view the information.
Incorporation Date:
May 30, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Interlife Pharma Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
21.97%
Total Operating Revenue
22.04%
Operating Profit
698.91%
EBITDA
698.91%
Net Profit/Loss for the Period
N/A
Total Assets
12.89%
Total Equity
49.72%
Operating Profit Margin
10.02%
Debt / Equity
-91.74%
Quick Ratio
-0.05%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?